Word

LUMYKRAS

Status

Dead

Status Code

606

Status Date

Monday, July 18, 2022

Serial Number

90531994

Mark Type

3000

Filing Date

Wednesday, February 17, 2021

Published for Opposition

Tuesday, October 19, 2021

Abandoned Date

Monday, July 18, 2022

Trademark Owner History

Amgen Inc, - Owner At Publication

Classifications

5 Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

The mark consists of "LUMYKRAS" with half circle design over "KRAS".
LUMMI KRAUS

Trademark Events

Jul 18, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 18, 2022

Abandonment - No Use Statement Filed

Dec 14, 2021

Noa E-Mailed - Sou Required From Applicant

Oct 19, 2021

Official Gazette Publication Confirmation E-Mailed

Oct 19, 2021

Published For Opposition

Sep 29, 2021

Notification Of Notice Of Publication E-Mailed

Sep 15, 2021

Teas Voluntary Amendment Received

Sep 16, 2021

Approved For Pub - Principal Register

Sep 13, 2021

Assigned To Examiner

May 20, 2021

Notice Of Design Search Code E-Mailed

May 19, 2021

New Application Office Supplied Data Entered In Tram

Feb 20, 2021

New Application Entered In Tram